Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Invirsa, Inc.
See All Filings
|
D | 2023-11-28 18:44:20 |
Amount To Be Raised
$999,998
Associated Brokers / Dealers
N/A
CIK Number
0001836108
Filed Document
0001836108-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-11-28 18:44:20
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
OHIO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Invirsa, Inc.
See All Filings
|
D | 2022-12-29 12:38:44 |
Amount To Be Raised
$7,700,000
Associated Brokers / Dealers
N/A
CIK Number
0001836108
Filed Document
0001836108-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-12-29 12:38:44
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
OHIO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Invirsa, Inc.
See All Filings
|
D/A | 2025-08-08 15:50:20 |
Amount To Be Raised
$2,860,000
Associated Brokers / Dealers
N/A
CIK Number
0001836108
Filed Document
0001836108-25-000003
Exclusions or Exemptions
506b
Accepted Date
2025-08-08 15:50:20
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
OHIO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Invirsa, Inc.
See All Filings
|
D | 2020-12-11 15:39:29 |
Amount To Be Raised
$40,245
Associated Brokers / Dealers
N/A
CIK Number
0001836108
Filed Document
0001836108-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-12-11 15:39:29
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
OHIO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Invirsa, Inc.
See All Filings
|
D | 2025-08-05 19:27:47 |
Amount To Be Raised
$2,832,000
Associated Brokers / Dealers
N/A
CIK Number
0001836108
Filed Document
0001836108-25-000002
Exclusions or Exemptions
506b
Accepted Date
2025-08-05 19:27:47
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
OHIO
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|